# Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea

> **NCT06282679** · NA · UNKNOWN · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Rosacea
- Botulinum Toxin

## Interventions

- **DRUG:** Botulinum Toxin Type A Injection [Botox]

## Key facts

- **NCT ID:** NCT06282679
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-06-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06282679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06282679, "Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06282679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*